dwa4949

5.5 million in volume

NASDAQ:BLPH   None
Large volume today, hopefully the momentum continues tomorrow. BIIB announced that it has dosed the first patient in the phase III study — TOPAZ-1. This news is from last week on Friday.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。